
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18021026
[patent_doc_number] => 20220372525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/848563
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848563 | Crispr enzymes and systems | Jun 23, 2022 | Issued |
Array
(
[id] => 19291800
[patent_doc_number] => 12031148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => RNA adeno-associated virus (RAAV) vector and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/836222
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 47
[patent_no_of_words] => 42288
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836222
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836222 | RNA adeno-associated virus (RAAV) vector and uses thereof | Jun 8, 2022 | Issued |
Array
(
[id] => 18287727
[patent_doc_number] => 20230103199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => INTEGRATION OF NUCLEIC ACID CONSTRUCTS INTO EUKARYOTIC CELLS WITH A TRANSPOSASE FROM ORYZIAS
[patent_app_type] => utility
[patent_app_number] => 17/832409
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832409 | INTEGRATION OF NUCLEIC ACID CONSTRUCTS INTO EUKARYOTIC CELLS WITH A TRANSPOSASE FROM ORYZIAS | Jun 2, 2022 | Pending |
Array
(
[id] => 17852171
[patent_doc_number] => 20220282213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => END-TO-END CELL THERAPY AUTOMATION
[patent_app_type] => utility
[patent_app_number] => 17/751999
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751999 | End-to-end cell therapy automation | May 23, 2022 | Issued |
Array
(
[id] => 17852172
[patent_doc_number] => 20220282214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => END-TO-END CELL THERAPY AUTOMATION
[patent_app_type] => utility
[patent_app_number] => 17/752021
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752021 | End-to-end cell therapy automation | May 23, 2022 | Issued |
Array
(
[id] => 17810624
[patent_doc_number] => 20220262459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES
[patent_app_type] => utility
[patent_app_number] => 17/735494
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735494 | Methods and systems for identifying target genes | May 2, 2022 | Issued |
Array
(
[id] => 18636416
[patent_doc_number] => 11761004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Safe harbor loci
[patent_app_type] => utility
[patent_app_number] => 17/716816
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 60
[patent_no_of_words] => 28322
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716816 | Safe harbor loci | Apr 7, 2022 | Issued |
Array
(
[id] => 18552482
[patent_doc_number] => 20230250492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Novel Cell Based Assay
[patent_app_type] => utility
[patent_app_number] => 17/708148
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17708148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/708148 | Novel Cell Based Assay | Mar 29, 2022 | Pending |
Array
(
[id] => 17733336
[patent_doc_number] => 20220218795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 17/707049
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707049 | Sequence specific antimicrobials | Mar 28, 2022 | Issued |
Array
(
[id] => 17733338
[patent_doc_number] => 20220218797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 17/707074
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707074 | Sequence specific antimicrobials | Mar 28, 2022 | Issued |
Array
(
[id] => 17733337
[patent_doc_number] => 20220218796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 17/707061
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707061 | Sequence specific antimicrobials | Mar 28, 2022 | Issued |
Array
(
[id] => 17807772
[patent_doc_number] => 20220259607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => MANIPULATION OF GENES INVOLVED IN SIGNAL TRANSDUCTION TO CONTROL FUNGAL MORPHOLOGY DURING FERMENTATION AND PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/699827
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 456
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699827 | MANIPULATION OF GENES INVOLVED IN SIGNAL TRANSDUCTION TO CONTROL FUNGAL MORPHOLOGY DURING FERMENTATION AND PRODUCTION | Mar 20, 2022 | Pending |
Array
(
[id] => 19300547
[patent_doc_number] => 20240229116
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR DETECTING MICRORNA IN BIOLOGICAL SAMPLE, COMPOSITION OF HYDROCHLORIDE OF NEUTRAL AMINO ACID, AND CONTAINER
[patent_app_type] => utility
[patent_app_number] => 18/279614
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279614 | METHOD FOR DETECTING MICRORNA IN BIOLOGICAL SAMPLE, COMPOSITION OF HYDROCHLORIDE OF NEUTRAL AMINO ACID, AND CONTAINER | Mar 16, 2022 | Pending |
Array
(
[id] => 19300547
[patent_doc_number] => 20240229116
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR DETECTING MICRORNA IN BIOLOGICAL SAMPLE, COMPOSITION OF HYDROCHLORIDE OF NEUTRAL AMINO ACID, AND CONTAINER
[patent_app_type] => utility
[patent_app_number] => 18/279614
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279614 | METHOD FOR DETECTING MICRORNA IN BIOLOGICAL SAMPLE, COMPOSITION OF HYDROCHLORIDE OF NEUTRAL AMINO ACID, AND CONTAINER | Mar 15, 2022 | Pending |
Array
(
[id] => 17688117
[patent_doc_number] => 20220195409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST
[patent_app_type] => utility
[patent_app_number] => 17/692108
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 349
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692108 | SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST | Mar 9, 2022 | Pending |
Array
(
[id] => 18364733
[patent_doc_number] => 20230146324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => MULTIPARAMETRIC NUCLEIC ACID OPTIMIZATION
[patent_app_type] => utility
[patent_app_number] => 17/683235
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683235 | MULTIPARAMETRIC NUCLEIC ACID OPTIMIZATION | Feb 27, 2022 | Abandoned |
Array
(
[id] => 18604893
[patent_doc_number] => 11746347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Simultaneous multiplex genome editing in yeast
[patent_app_type] => utility
[patent_app_number] => 17/679203
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 41
[patent_no_of_words] => 35297
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679203 | Simultaneous multiplex genome editing in yeast | Feb 23, 2022 | Issued |
Array
(
[id] => 18329490
[patent_doc_number] => 11634719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Curing for recursive nucleic acid-guided cell editing
[patent_app_type] => utility
[patent_app_number] => 17/676210
[patent_app_country] => US
[patent_app_date] => 2022-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 51
[patent_no_of_words] => 36429
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676210 | Curing for recursive nucleic acid-guided cell editing | Feb 19, 2022 | Issued |
Array
(
[id] => 17946120
[patent_doc_number] => 20220333137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES
[patent_app_type] => utility
[patent_app_number] => 17/585694
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585694 | METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES | Jan 26, 2022 | Pending |
Array
(
[id] => 17867430
[patent_doc_number] => 20220290166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST
[patent_app_type] => utility
[patent_app_number] => 17/584028
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584028 | Expression constructs and methods of genetically engineering methylotrophic yeast | Jan 24, 2022 | Issued |